BUDAPEST, Hungary, March 28, 2018 /PRNewswire/ --
The consolidated EBITDA for the Darholding companies rose sharplyby 57%, compared with previous year, partly as a result of our continuous reorganization efforts, while the consolidated revenue increased by 5% to EUR 9.6 million. As a recognition of our innovative stance, three EU grants
Darholding is a Budapest based upstream innovation incubating organization with interests in scientific research in pharmaceuticals, agrochemicals, fine chemicals, flavors and fragrances, laboratory instrumentation and chemistry development in Space. It operates globally through a network of companies who are all pioneers in their chosen field.
Contact: Gergely Darvas Investment Director Darholding Ltd firstname.lastname@example.org +36-1-880-8500
SOURCE Darholding Ltd.
Subscribe to our Free Newsletters!